Not Registered? Register Now.

1. My Profile >2. Additional Information

By submitting below you certify that you have read and agree to our privacy policy.


WisdomTree Europe Hires Head of Sales

Thursday 23rd April '15

Hector McNeil, Co-CEO

WisdomTree Europe Hires Head of Sales

London, 23 April 2015: WisdomTree, an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor, and pioneer of dividend-weighted smart beta ETFs, announces the hire of Nizam Hamid as Head of Sales for WisdomTree Europe.

Mr. Hamid’s vast ETF industry experience includes leadership roles at Deutsche Bank, BlackRock and Lyxor.  As Managing Director, in Portfolio and Index Strategy at Deutsche Bank, Mr. Hamid spent 10 years building their global ETF research strategy. After this role, Nizam was Managing Director, as Head of Sales Strategy for EMEA at Blackrock, where he was instrumental in a number of new product development initiatives.  He then moved to Lyxor Asset Management. Whilst working at Lyxor, he was a Managing Director, as Head of ETF Strategy and Deputy Head of ETFs. Nizam managed the majority of ETF product development and structuring, and worked closely with external Delta One trading and sales desks across Europe.  Previous firms have also included the FTSE Group and C8 Investments. Nizam started his career as a Quantitative Analyst in the 1990s.

Hector McNeil, Co-CEO of WisdomTree Europe said:

“Hiring someone of Nizam’s experience is a major coup for WisdomTree Europe. He brings a wealth of senior experience from three of the largest European ETF providers. He will add significant depth to our management team.

Nizam’s focus will be to grow and manage the dynamic sales team we have put in place in Europe and maximise our footprint across the five markets where we are listed in, and the many others where we are registered for sale. He will focus equally on the Boost short and leveraged ETP platform as well as the rapidly growing WisdomTree Europe UCITS dividend weighted smart beta ETF platform.”

WisdomTree Europe’s current list of equity UCITS ETFs stands at seven, and are listed on the London Stock Exchange, Borsa Italiana, Xetra, SIX Swiss Exchange, and the Irish Stock Exchange.



Notes to Editors

About WisdomTree Europe Ltd

WisdomTree Investments, Inc., through its subsidiaries in the U.S. and Europe, including WisdomTree Europe Ltd based in London, is an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor and asset manager.  WisdomTree offers products covering equities, fixed income, currencies, commodities and alternative strategies.  Through WisdomTree Europe Ltd, it sponsors WisdomTree UCITS ETFs and BOOST short and leverage ETPs. WisdomTree currently has approximately $60.3 billion (as of 14 April 2015) in assets under management globally.  For more information, please visit

WisdomTree® is the marketing name for WisdomTree Investments, Inc. and its subsidiaries worldwide.  


This document is issued by WisdomTree Europe Ltd (“WTE”) an appointed representative of Mirabella Financial Services LLP, which is authorised and regulated by the United Kingdom Financial Conduct Authority (“FCA”). The products discussed in this document are issued by WisdomTree Issuer PLC (“Issuer”), an umbrella investment company with variable capital having segregated liability between its funds organised under the laws of Ireland as a public limited company and authorised by the Central Bank of Ireland (“CBI”). The Issuer is organised as an Undertaking for Collective Investment in Transferable Securities (“UCITS”) under the laws of Ireland and shall issue a separate class of shares ("Shares”) representing each fund. Investors should read the prospectus of the Issuer ( “Prospectus”) before investing and should refer to the section of the Prospectus entitled ‘Risk Factors’ for further details of risks associated with an investment in the Shares. Any decision to invest should be based on the information contained in the Prospectus. This product may not be available or suitable for you. This document does not constitute investment advice nor an offer for sale nor a solicitation of an offer to buy Shares. This document should not be used as the basis for any investment decision.

The price of any Shares may go up or down and an investor may not get back the amount invested. Past performance is not a reliable indicator of future performance. Any historical performance included in this document may be based on back testing. Back testing is the process of evaluating an investment strategy by applying it to historical data to simulate what the performance of such strategy would have been. Back tested performance is purely hypothetical and is provided in this document solely for informational purposes. Back tested data does not represent actual performance and should not be interpreted as an indication of actual or future performance. The value of the Shares may be affected by exchange rate movements.

For United Kingdom Investors: The Fund is a recognised scheme under section 264 of the Financial Services and Markets Act 2000 and so the Prospectus may be distributed to investors in the United Kingdom. Copies of all documents are available in the United Kingdom from

This document is not, and under no circumstances is to be construed as, an advertisement or any other step in furtherance of a public offering of shares in the United States or any province or territory thereof, where none of the Issuer or the Shares are authorised or registered for distribution and where no prospectus of the Issuer has been filed with any securities commission or regulatory authority. Neither this document nor any copy hereof should be taken, transmitted or distributed (directly or indirectly) into the United States. Neither the Issuer nor any securities issued by it have been or will be registered under the United States Securities Act of 1933 or the Investment Company Act of 1940 or qualified under any applicable state securities statutes.